重度主动脉瓣狭窄合并非对称性室间隔肥厚患者瓣置换术后残余左心室肥厚与不良临床结局
该回顾性研究纳入59例因重度主动脉瓣狭窄合并非对称性室间隔肥厚行主动脉瓣置换术的患者,按术后2年左心室质量指数分为正常组与残余肥厚组。结果显示左心房尺寸术后早期迅速下降并于3个月平台,左心室质量于2年达最低;术前左心室质量指数较高是残余肥厚的独立预测因素,残余肥厚与长期非致死性心血管住院率升高相关。
要点
- 左心房逆重构在术后3个月达最大恢复,左心室逆重构在术后2年达最大恢复。
- 术前左心室质量指数较高是术后2年残余左心室肥厚的独立预测因素。
- 术后2年残余左心室肥厚与较高的非致死性心血管住院率相关。
核心结论
- 重度主动脉瓣狭窄合并非对称性室间隔肥厚患者行主动脉瓣置换术后,左心房最大恢复在3个月,左心室最大恢复在2年。
- 术前左心室质量指数较高可能导致术后残余肥厚,并与不良临床结局相关。
研究设计与样本
- 回顾性队列研究,纳入59例因重度主动脉瓣狭窄合并非对称性室间隔肥厚行主动脉瓣置换术的连续患者。
主要发现
- 室间隔厚度和左心室质量指数逐渐下降,术后2年达最低点;左心房内径术后早期迅速下降,3个月时平台。
- 多变量分析显示术前左心室质量指数较高[比值比6.36(1.678-24.11);P=0.007]是术后2年残余肥厚的独立预测因素。
- Cox比例风险模型显示术后峰值流速较高[风险比6.715(1.405-32.104);P=0.017]是长期非致死性心血管住院的独立预测因素。
- 术后2年残余肥厚患者非致死性心血管住院率较高(P=0.014)。
临床怎么用
- 对于重度主动脉瓣狭窄合并非对称性室间隔肥厚行主动脉瓣置换术的患者,应关注术前左心室质量指数以评估残余肥厚风险。
- 术后2年残余左心室肥厚提示需加强随访,警惕非致死性心血管住院风险。
局限性
- 回顾性研究设计。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: The aim of this study is to describe the temporal pattern of left atrial (LA) and left ventricular (LV) reverse remodelling and to evaluate the impact of residual LV hypertrophy on the prognosis of patients with severe aortic stenosis and asymmetric septal hypertrophy undergoing aortic valve replacement (AVR). METHODS: We retrospectively reviewed 59 consecutive patients who underwent AVR for severe aortic stenosis and asymmetric septal hypertrophy. They were divided into the normal LV mass group and the residual LV hypertrophy group according to the LV mass index (LVMI) 2 years after AVR. Thirty patients were eligible for analysis of the time-dependent changes in LA and LV reverse remodelling. RESULTS: The interventricular septal thickness and LVMI gradually decreased and reached their lowest points 2 years after operation, whereas the LA dimension rapidly decreased in the early postoperative period and plateaued at 3 months. The multivariable analysis revealed a higher preoperative LVMI [odds ratio 6.36 (1.678-24.11); P = 0.007] as an independent predictor of residual hypertrophy 2 years after operation. The Cox proportional hazards model showed that a higher postoperative peak velocity [hazard ratio 6.715 (1.405-32.104); P = 0.017] was an independent predictor of long-term non-fatal cardiovascular hospitalization. Patients with residual hypertrophy 2 years after AVR had a higher rate of non-fatal cardiovascular hospitalization (P = 0.014). CONCLUSIONS: For patients with severe aortic stenosis and asymmetric septal hypertrophy, maximum LA recovery occurred 3 months after AVR, whereas maximum LV recovery occurred 2 years thereafter. A higher preoperative LVMI may lead to postoperative residual hypertrophy, which is associated with adverse clinical outcomes.
引用
- Xu H, Duan Y, Yuan X, et al. Residual left ventricular hypertrophy with adverse clinical outcomes in patients with severe aortic stenosis and asymmetric septal hypertrophy after aortic valve replacement. Eur J Cardiothorac Surg. 2019. PMID: 30698739. doi:10.1093/ejcts/ezy486
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。